Skip to content

Envoy Medical COCH Interest Expense, Nonoperating

Interest Expense, Nonoperating at other companies

CTO
Citius Oncology, Inc.CTOR
$33.03K
Spectral AI, Inc. logo
Spectral AI, Inc.MDAI
$258K+1,190%
XTI Aerospace, Inc. logo
XTI Aerospace, Inc.XTIA
$154K-29.0%
Cal-Maine Foods logo
Cal-Maine FoodsCALM
$153K+11.5%
Dakota Gold logo
Dakota GoldDC
$34.37K
Evommune
 logo
Evommune EVMN
$25.8K-72.9%

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Envoy Medical’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's interest expense, nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's interest expense, nonoperating?
Envoy Medical (COCH) reported interest expense, nonoperating of $0 in Q4 2025.
How has Envoy Medical's interest expense, nonoperating changed year-over-year?
Envoy Medical's interest expense, nonoperating decreased by 100.0% year-over-year, from $384K to $0.
What does interest expense, nonoperating mean?
Includes all interest costs incurred on debt obligations that are not directly related to core operating activities. This figure provides insight into the company's cost of capital and its reliance on external financing to fund operations or bridge liquidity gaps. Monitoring this helps assess the sustainability of the company's debt burden.